Literature DB >> 28490262

Methods for safety signal detection in healthcare databases: a literature review.

Mickael Arnaud1,2, Bernard Bégaud1,2,3, Nicolas Thurin1,2,4, Nicholas Moore1,2,3,4, Antoine Pariente1,2,3,4, Francesco Salvo1,2,3.   

Abstract

INTRODUCTION: With increasing availability, the use of healthcare databases as complementary data source for drug safety signal detection has been explored to circumvent the limitations inherent in spontaneous reporting. Areas covered: To review the methods proposed for safety signal detection in healthcare databases and their performance. Expert opinion: Fifteen different data mining methods were identified. They are based on disproportionality analysis, traditional pharmacoepidemiological designs (e.g. self-controlled designs), sequence symmetry analysis (SSA), sequential statistical testing, temporal association rules, supervised machine learning (SML), and the tree-based scan statistic. When considering the performance of these methods, the self-controlled designs, the SSA, and the SML seemed the most interesting approaches. In the perspective of routine signal detection from healthcare databases, pragmatic aspects such as the need for stakeholders to understand the method in order to be confident in the results must be considered. From this point of view, the SSA could appear as the most suitable method for signal detection in healthcare databases owing to its simple principle and its ability to provide a risk estimate. However, further developments, such as automated prioritization, are needed to help stakeholders handle the multiplicity of signals.

Keywords:  Drug safety; data mining; pharmacoepidemiology; pharmacovigilance; signal detection

Mesh:

Year:  2017        PMID: 28490262     DOI: 10.1080/14740338.2017.1325463

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  20 in total

1.  An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.

Authors:  Mickael Arnaud; Bernard Bégaud; Frantz Thiessard; Quentin Jarrion; Julien Bezin; Antoine Pariente; Francesco Salvo
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

2.  Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.

Authors:  Ed Whalen; Manfred Hauben; Andrew Bate
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

3.  Risk of excessive sleepiness in sleep restriction therapy and cognitive behavioral therapy for insomnia: a randomized controlled trial.

Authors:  Philip Cheng; David Kalmbach; Cynthia Fellman-Couture; J Todd Arnedt; Andrea Cuamatzi-Castelan; Christopher L Drake
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

4.  An Implementation and Visualization of the Tree-Based Scan Statistic for Safety Event Monitoring in Longitudinal Electronic Health Data.

Authors:  Stephen E Schachterle; Sharon Hurley; Qing Liu; Kenneth R Petronis; Andrew Bate
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

5.  "Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?

Authors:  Robert Ball; Gerald Dal Pan
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

6.  Characterizing non-heroin opioid overdoses using electronic health records.

Authors:  Amelia J Averitt; Benjamin H Slovis; Abdul A Tariq; David K Vawdrey; Adler J Perotte
Journal:  JAMIA Open       Date:  2019-11-26

7.  Nurse-led medicines' monitoring in care homes study protocol: a process evaluation of the impact and sustainability of the adverse drug reaction (ADRe) profile for mental health medicines.

Authors:  Sue Jordan; Timothy Banner; Marie Gabe-Walters; Jane M Mikhail; Jeff Round; Sherrill Snelgrove; Mel Storey; Douglas Wilson; David Hughes
Journal:  BMJ Open       Date:  2018-09-28       Impact factor: 2.692

8.  Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.

Authors:  Andrew Bate; Ken Hornbuckle; Juhaeri Juhaeri; Stephen P Motsko; Robert F Reynolds
Journal:  Ther Adv Drug Saf       Date:  2019-08-05

9.  Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.

Authors:  Daniele Sartori; Jeffrey K Aronson; Igho J Onakpoya
Journal:  Syst Rev       Date:  2020-08-13

Review 10.  Assessment of Medication Safety Using Only Dispensing Data.

Authors:  Nicole Pratt; Elizabeth Roughead
Journal:  Curr Epidemiol Rep       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.